Logo - springer
Slogan - springer

| European Journal of Drug Metabolism and Pharmacokinetics - incl. option to publish open access (Editorial Board)

European Journal of Drug Metabolism and Pharmacokinetics

European Journal of Drug Metabolism and Pharmacokinetics

Editor-in-Chief: Jasbir Singh

ISSN: 0378-7966 (print version)
ISSN: 2107-0180 (electronic version)

Journal no. 13318

Consulting Editor

Dr. Fanchon Bourasset, Faculty of Pharmacy, Department Clinical Pharmacy and Pharmacokinetics, University Paris Descartes, Paris, France

Founder and former Editor-in-Chief

Prof. Achilles Benakis †

Editorial board members

Dr. Soo Kyung Bae, College of Pharmacy, The Catholic University of Korea, Kyunggido, South Korea

Dr. Patrick Callery, West Virginia University, Department of Basic Pharmaceutical Sciences, Morgantown, WV, USA

Dr. Dario Cattaneo, ASST Fatebenefratelli Sacco University Hospital, Department of Laboratory Medicine, Milan, Italy

Pr. Christian Cavé, Chemistry Department, Faculty of Pharmacy, Paris Sud University, Chatenay-Malabry, France

Dr. Salvatore Cisternino, Pharmacokinetics and Clinical Pharmacy Department, Faculty of Pharmacy, Paris 5 University, Paris, France

Dr. Patrick M. Dansette, Chemistry and Biochemistry Pharmacological and Toxicological Laboratory, Paris 5 University, Paris, France

Pr. Jules Desmeules, Division of Clinical Pharmacology and Toxicology, Geneva University Hospitals, Switzerland

Pr. Padma V. Devarajan, Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, India

Dr. Fawzy Elbarbry, School of Pharmacy, Pacific University, Hillsboro, OR, USA

Pr. Robert Farinotti, Pharmacokinetics and Clinical Pharmacy Department, Faculty of Pharmacy, Paris Sud University, Chatenay-Malabry, France

Dr. David Foster, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia

Dr. Maria Jesus Garrido, Department of Pharmacy and Pharmaceutical Technology, University of Navarra, Pamplona, Spain

Dr. Marko Goličnik, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Pr. Antonis Goulas, 1st Laboratory of Pharmacology, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

Dr. Tomasz Grabowski, Polpharma Biologics, Gdański Park Naukowo-Technologiczny, Gdańsk, Poland

Dr. Olaf Grisk, Department of Physiology, Ernst-Moritz-Arndt-University, Greifswald, Germany

Dr. Mounira Hamoudi, Pharmaceutical Sciences and Biological Laboratory of Pharmaceutical Technology, University Lille Norde De France, Lille, France

Pr. Sam Harirforoosh, Gatton College of Pharmacy, East Tennessee State University, Johnson City, TN, USA

Pr. Slobodan M Jankovic, Faculty of Medical Science, University of Kragujevac, Kragujevic, Serbia

Dr. Vincent Jullien, Cochin-Saint-Vincent de Paul Hospital, Pharmacology Department, Paris 5 University, Paris, France

Dr. Ke Lan, West China School of Pharmacy, Sichuan University, Chengdu, Sichuan, China

Dr. Guo-Fu Li, Medical Research Center, Subei People's Hospital, Shanghai, Yangzhou, China

Dr Weirong Li, Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangdong, China

Pr. Momir Mikov, Medical Faculty and Department of Pharmacology and Toxicology, University of Novi Sad, Republic of Serbia

Dr. Steve Mitchell, Department of Biomolecular Medicine, Faculty of Medicine, Imperial College London, London, UK

Pr. Fathi Moussa, Département Chimie, Université Paris Sud, Orsay Cedex, France

Pr. Gian Maria Pacifici, Medical School, Department of Neurosciences, Section of Pharmacology, University of Pisa, Pisa, Italy

Pr. Roberto Padrini, University of Padova, Department of Medicine, Padova, Italy

Dr. Scott R. Penzak, University of North Texas System College of Pharmacy, Department of Pharmacotherapy, Fort Worth, TX, USA

Pr. Wei Ren, Institue of Clinical Chemistry, Guangzhouu University of Chinese Medicine, Guangdong, China

Pr. Michael Weiss, Department of Pharmacology, Martin Luther University, Halle, Germany

Pr. Kyle J. Wilby, College of Pharmacy, Qatar University, Doha, Qatar

Read this Journal on Springerlink

For authors and editors

  • Journal Citation Reports®
    2016 Impact Factor
  • 1.400
  • Aims and Scope

    Aims and Scope


    The European Journal of Drug Metabolism and Pharmacokinetics covers all aspects of pre-clinical and clinical pharmacokinetics & pharmacodynamics, including drug disposition, metabolism, transport and interactions, therapeutic drug monitoring, pharmacokinetic/pharmacodynamic relationship, bioavailability and biopharmacy. The journal welcomes publications in the field of pharmacokinetic and pharmacodynamic modeling. Analytical methods validation linked with a pharmacokinetic study will also be considered.

    The journal publishes original research articles, short communications, review articles, leading articles, current opinion articles on special topics, and conference proceedings. Letters to the Editor are welcomed and will be considered for publication.

    Articles published in European Journal of Drug Metabolism and Pharmacokinetics may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances.

    The European Journal of Drug Metabolism and Pharmacokinetics publishes six issues a year.

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for Authors

    Instruction for authors


  • Important Information for Authors
  • Author Academy: Training for Authors
  • Conflict of Interest form (doc, 84 kB)
  • Copyright Information

    Copyright Information


    Copyright Information

    For Authors

    Submission of a manuscript implies: that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out.

    Author warrants (i) that he/she is the sole owner or has been authorized by any additional copyright owner to assign the right, (ii) that the article does not infringe any third party rights and no license from or payments to a third party is required to publish the article and (iii) that the article has not been previously published or licensed. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to Springer (respective to owner if other than Springer) becomes effective if and when a Copyright Transfer Statement is signed or transferred electronically by the corresponding author. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Springer.

    The copyright to this article, including any graphic elements therein (e.g. illustrations, charts, moving images), is assigned for good and valuable consideration to Springer effective if and when the article is accepted for publication and to the extent assignable if assignability is restricted for by applicable law or regulations (e.g. for U.S. government or crown employees).

    The copyright assignment includes without limitation the exclusive, assignable and sublicensable right, unlimited in time and territory, to reproduce, publish, distribute, transmit, make available and store the article, including abstracts thereof, in all forms of media of expression now known or developed in the future, including pre- and reprints, translations, photographic reproductions and microform. Springer may use the article in whole or in part in electronic form, such as use in databases or data networks for display, print or download to stationary or portable devices. This includes interactive and multimedia use and the right to alter the article to the extent necessary for such use.

    Authors may self-archive the Author's accepted manuscript of their articles on their own websites. Authors may also deposit this version of the article in any repository, provided it is only made publicly available 12 months after official publication or later. He/she may not use the publisher's version (the final article), which is posted on SpringerLink and other Springer websites, for the purpose of self-archiving or deposit. Furthermore, the Author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com".

    Prior versions of the article published on non-commercial pre-print servers like arXiv.org can remain on these servers and/or can be updated with Author's accepted version. The final published version (in pdf or html/xml format) cannot be used for this purpose. Acknowledgement needs to be given to the final publication and a link must be inserted to the published article on Springer's website, accompanied by the text "The final publication is available at link.springer.com". Author retains the right to use his/her article for his/her further scientific career by including the final published journal article in other publications such as dissertations and postdoctoral qualifications provided acknowledgement is given to the original source of publication.

    Author is requested to use the appropriate DOI for the article. Articles disseminated via link.springer.com are indexed, abstracted and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    For Readers

    While the advice and information in this journal is believed to be true and accurate at the date of its publication, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the publisher (respective the copyright owner if other than Springer). The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    Springer has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Springer content. For permission to reuse our content please locate the material that you wish to use on link.springer.com or on springerimages.com and click on the permissions link or go to copyright.com, then enter the title of the publication that you wish to use. For assistance in placing a permission request, Copyright Clearance Center can be connected directly via phone: +1-855-239-3415, fax: +1-978-646-8600, or e-mail: info@copyright.com.

    © Springer-Verlag France

Alerts for this journal


Get the table of contents of every new issue published in European Journal of Drug Metabolism and Pharmacokinetics.

Additional information